Top 10 Companies in the Hydrolyzed Silk Market (2026): Market Leaders Powering Global Innovation

MARKET INSIGHTS

Global hydrolyzed silk market was valued at USD 32.5 million in 2024. The market is projected to grow from USD 35.8 million in 2025 to USD 62.1 million by 2032, exhibiting a CAGR of 7.3% during the forecast period.

Hydrolyzed silk is a premium biomaterial derived from silk cocoons through controlled hydrolysis. This process breaks down silk fibroin proteins into smaller peptides while preserving beneficial properties such as biocompatibility, moisture retention, and UV protection. The resulting product finds applications across cosmetics, pharmaceuticals, and biomedical sectors due to its unique combination of natural origin and functional performance.

The market growth is driven by increasing demand for sustainable ingredients in personal care products, particularly in anti‑aging formulations where silk peptides demonstrate exceptional efficacy. However, supply chain complexities in raw silk procurement present ongoing challenges. Recent innovations include advanced processing techniques that enhance protein yield while maintaining purity standards, as seen in new production facilities commissioned by key Asian manufacturers in early 2024.

Hydrolyzed Silk Market – View in Detailed Research Report

Top 10 Companies in the Hydrolyzed Silk Market

🔟 1. Huzhou Xintiansi Bio‑tech

Headquarters: Huzhou, China
Key Offering: Full‑chain hydrolyzed silk production, from raw cocoons to high‑purity peptides for cosmetics and pharmaceuticals.

Huzhou Xintiansi has positioned itself as a vertically integrated producer, controlling every stage of sericulture, extraction, and purification. The company’s proprietary enzymatic hydrolysis platform reduces processing time by 30% while preserving peptide bioactivity, enabling rapid turnaround for cosmetic formulators.

Sustainability & Growth Initiatives:

• Investing 12% of annual revenue in research on green extraction solvents.
• Partnering with local farms to implement regenerative silkworm farming practices.
• Expanding capacity by 25% to meet rising demand in Asia‑Pacific and Europe.

9️⃣ 2. LANXESS

Headquarters: Ludwigshafen, Germany
Key Offering: Advanced silk peptide blends for high‑performance skincare and drug delivery systems.

LANXESS’s patented hydrolysis technology delivers peptides with controlled molecular weight distribution, a critical factor for skin penetration and drug release. The company’s focus on precision engineering has secured a 18% share of the European market in 2024.

Sustainability & Growth Initiatives:

• Developing a closed‑loop processing system that recycles by‑products into bio‑fertilizers.
• Launching a joint venture with a leading cosmetic brand to co‑develop a clean‑beauty line.
• Targeting a 15% CAGR in the EU market through strategic acquisitions.

8️⃣ 3. Croda International

Headquarters: Holton, United Kingdom
Key Offering: High‑purity hydrolyzed silk for pharmaceutical excipients and wound care products.

Croda’s expertise in specialty chemicals complements its silk portfolio, offering formulations that meet stringent regulatory standards. The company’s recent expansion into North America has increased its presence in the medical device sector.

Sustainability & Growth Initiatives:

• Investing in biorefinery projects that convert silk waste into renewable energy.
• Collaborating with universities to develop silk‑based biodegradable polymers.
• Expanding R&D budget by 18% to accelerate product innovation.

7️⃣ 4. Zhejiang Xingyue Biotechnology

Headquarters: Zhejiang, China
Key Offering: Customized silk peptide blends for nutraceuticals and functional foods.

Leveraging China’s extensive silk supply chain, Zhejiang Xingyue tailors peptide profiles to enhance gut health and immune modulation. The company’s focus on nutraceuticals aligns with rising consumer interest in functional ingredients.

Sustainability & Growth Initiatives:

• Implementing water‑recycling protocols across all production lines.
• Partnering with local farmers to promote organic sericulture.
• Planning a 20% increase in production capacity for the next three years.

6️⃣ 5. Chongqing Haifan Biochemical

Headquarters: Chongqing, China
Key Offering: Silk‑derived scaffolds for tissue engineering and regenerative medicine.

Haifan Biochemical’s research team has developed silk scaffolds that support osteogenic differentiation, achieving 92% cellular viability in pre‑clinical studies. The company is actively pursuing FDA clearance for its scaffold platform.

Sustainability & Growth Initiatives:

• Adopting a zero‑waste policy in the manufacturing process.
• Collaborating with biotech firms to explore silk‑based drug delivery vehicles.
• Expanding into the U.S. market through strategic licensing agreements.

5️⃣ 6. Zhejiang Silk Seekers

Headquarters: Zhejiang, China
Key Offering: High‑purity powder and liquid hydrolyzed silk for premium cosmetics.

After a $12 million facility upgrade, Zhejiang Silk Seekers increased output by 40% and now serves major global beauty brands. The company’s focus on high‑purity grades has positioned it as a preferred supplier for anti‑aging formulations.

Sustainability & Growth Initiatives:

• Investing in renewable energy sources for production facilities.
• Implementing traceability systems to guarantee raw‑material provenance.
• Targeting a 10% CAGR in the Asia‑Pacific region through strategic partnerships.

4️⃣ 7. Seidecosa

Headquarters: Seville, Spain
Key Offering: Medical‑grade hydrolyzed silk for wound dressings and drug carriers.

Seidecosa secured FDA approval for its medical‑grade silk proteins in Q1 2025, opening access to the U.S. market. The company’s product line includes hydrogel dressings that accelerate healing in chronic wounds.

Sustainability & Growth Initiatives:

• Adopting a circular economy model by recycling process effluents.
• Collaborating with European research institutes on silk‑based biomaterials.
• Expanding production capacity by 15% to meet growing demand in the EU and U.S.

3️⃣ 8. Suzhou Suhao Bio

Headquarters: Suzhou, China
Key Offering: Silk peptide blends for nutraceuticals and dietary supplements.

Suhao Bio focuses on producing peptides that support metabolic health. The company’s formulations are marketed under several leading health‑tech brands in China and Southeast Asia.

Sustainability & Growth Initiatives:

• Implementing energy‑efficient processing technologies.
• Partnering with organic farms to secure sustainable raw silk.
• Planning a 12% increase in R&D spend to develop next‑generation peptide blends.

2️⃣ 9. Caresilk

Headquarters: Milan, Italy
Key Offering: High‑purity hydrolyzed silk for cosmetic and pharmaceutical applications.

Caresilk’s product portfolio includes peptide‑rich serums and drug delivery matrices. The company emphasizes rigorous quality control, meeting both EU cosmetic regulations and pharmaceutical GMP standards.

Sustainability & Growth Initiatives:

• Investing in low‑impact extraction solvents to reduce chemical waste.
• Collaborating with Italian universities on silk‑based biodegradable polymers.
• Expanding into the Middle East market through joint ventures.

1️⃣ 10. Kelisema Srl

Headquarters: Milan, Italy
Key Offering: Silk‑based anti‑aging formulations and cosmetic ingredients.

Kelisema’s partnership with L’Oréal in 2024 resulted in a new line of silk‑infused serums that achieved 30% greater hydration retention in clinical trials. The company’s focus on clean‑beauty ingredients aligns with global consumer preferences for natural, sustainable products.

Sustainability & Growth Initiatives:

• Developing a closed‑loop production system to minimize waste.
• Launching a sustainability certification program for suppliers.
• Planning a 20% expansion of its production footprint in Europe.

Download FREE Sample Report

Get Full Report

Outlook: The Future of Hydrolyzed Silk Market

Over the next decade, the hydrolyzed silk market is poised to expand as consumer demand for natural, high‑performance ingredients continues to rise. The convergence of advanced processing technologies and robust regulatory support in key regions—particularly Asia‑Pacific, Europe, and North America—will drive adoption across cosmetics, pharmaceuticals, and smart textiles.

Future Trends Shaping the Market

• Growth of bio‑engineered silk proteins with tailored functional properties for specific therapeutic applications.
• Expansion of silk‑based smart textiles offering temperature regulation and antimicrobial features for high‑performance apparel.
• Increasing investment in circular economy models that recycle silk waste into renewable energy and bio‑fertilizers.
• Acceleration of regulatory harmonization for biomaterials, reducing approval timelines for medical devices and cosmetics.
• Emergence of integrated supply‑chain platforms that connect sericulture farms directly with end‑users, enhancing traceability and reducing lead times.